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Summary  25 
Background: Successful laboratory detection of carbapenemase-producing Enterobacteriaceae (CPE) 26 
in patient surveillance samples is a diagnostic challenge. In the absence of a gold standard to use for 27 
screening rectal swabs for CPE, many phenotypic, genotypic, culture and non-culture based assays 28 
have been proposed for identifying these bacteria. 29 
Aim: To develop and optimise a CPE screening protocol capable of identifying all commonly 30 
encountered CPE, including those producing OXA-48-like carbapenemases 31 
Methods: Faropenem (CAT-ID) susceptibility was performed on 507 presumptive CPE isolated from 32 
diagnostic samples and CPE rectal screens between March and August 2016. Results from this CPE 33 
screening method were compared to those from direct culture on mSuperCARBATM, temocillin 34 
enrichment culture and use of an antibiotic resistance algorithm, to determine the optimal method 35 
to employ in the detection of CPE.  36 
Findings: Faropenem was a poor predictor of carbapenemase production (58% true positives)The 37 
combination of a temocillin enrichment stage and interpretitve reading of antibiotic resistance 38 
phenotypes improved the recovery and identification of CPE significantly (91% true-positives), 39 
particularly for OXA-48 producers (P = 0.03). 40 
Conclusion: The combination of temocillin enrichment,a selective chromogenic media and an 41 
antibiotic resistance-based algorithm significantly improved the detection of all CPE recovered from 42 
routine and targeted surveillance samples. 43 
 44 








Introduction  51 
Acquired resistance to carbapenems in Enterobacteriaceae is a global problem facilitated by 52 
plasmid-mediated spread of class A (KPC), B (IMP, VIM, NDM) and D (OXA-48-like) β-lactamases 53 
among multiple species (E. coli, Klebsiella, Enterobacter, Citrobacter species). In the UK, there are 54 
reports of hospital outbreaks which are increasingly difficult to control and also overlap with spread 55 
into and within the community.1-4  56 
 57 
Accurate detection of carbapenemase-producing Enterobacteriaceae (CPE) is fundamental to any 58 
strategy aimed at addressing this problem. Many  methods have been used to identify CPE including 59 
phenotypic susceptibility tests, selective culture media, immunochromatographic assays, specific 60 
PCRs and sequenced based molecular tests; all with varying degrees of sensitivity and specificity.5, 6, 8-61 
10 Furthermore, identification of CPE from rectal swabs, commonly used in surveillance and outbreak 62 
screening, is hindered by the lack of a gold standard test. Resistance to carbapenems as the sole 63 
marker is complicated by the wide MIC distribution among the wild type population of CPE. 64 
Thisspans current EUCAST and CLSI breakpoints (0.25 – 8mg/L), and may lead to many CPEs being 65 
‘missed’, especially those that just produce OXA-48.5, 6 With such diversity  in the prevalence and 66 
epidemiology of carbapenem resistant strains  in the UK, there is an urgent need for a robust 67 
laboratory screening protocol that is capable of detecting all CPEs.1 68 
 69 
Public Health England (PHE) guidance advocates the use of a chromogenic media and resistance to 70 
an indicator carbapenem for the primary isolation of CPE from rectal screening samples.7 Using this 71 
guidance as a basis, we assessed the utility of temocillin enrichment cultures together with 72 
interpretitive reading of the antibiotic susceptibility profile, as a reliable screening algorithm for 73 
enhanced accurate identification of CPE, particularly for OXA-48.10 74 
Methods  75 
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This was a single-centre study performed as part of our continuous service development but in the 76 
presence of an on-going OXA-48 outbreak (June 2016 – current).  77 
 78 
Susceptibility to faropenem  79 
Bacterial culture 80 
All screening swabs were inoculated on mSuperCARBATM chromogenic agar (E&O Laboratories, 81 
Bonnybridge, UK) and incubated for 18-24 hours at 37°C. Pink (E. coli) and blue (other 82 
Enterobacteriaceae) colonies were identified by MALDI-TOF mass spectrometry (Bruker Daltonik 83 
GmbH, Bremen, Germany). 84 
 Urinary isolates underwent faropenem susceptibility testing if they were resistant to cefpodoxime 85 
(BSAC disc diffusion) and all other isolates from other diagnostic specimens underwent faropenem 86 
susceptibility testing if they were reported resistant to ≥1 carbapenem using the Microscan NM44 87 
?(MicroScan, Beckman Coulter, High Wycombe, UK). 88 
  89 
Antibiotic susceptibility testing (AST) 90 
AST (disc diffusion) was performed with meropenem (10μg), ertapenem (10μg), temocillin (30μg) 91 
and piperacillin-tazobactam (75/10μg), according to BSAC guidelines (v14, 2015). Discs were 92 
supplied by Thermo ScientificTM OxoidTM (Basingstoke, UK).  93 
 94 
Faropenem susceptibility testing  95 
Faropenem (CAT-ID, Mast Group Ltd, Bootle, UK) susceptibility testing was performed according to 96 
the manufacturer’s instructions. Faropenem results were reported as either CPE positive (no zone 97 
present/double zone/single colonies within zone of inhibition) or CPE negative (zone of inhibition 98 
observed). All CPE positives were referred for reference testing by PCR (AMRHL..), which was 99 







A retrospective evaluation of faropenem (CAT-ID) susceptibility results, for all suspected CPE isolated 105 
from 507 specimens, was performed, between March and August 2016. These included 25 rectal 106 
swabs taken for CPE screening and 482 diagnostic specimens (455 urines, 9 blood cultures, 7 wound 107 
swabs, 6 fluids, 3 respiratory specimens, 1 tip and 1 tissue). Susceptibility results were also reviewed 108 
in conjunction with reference molecular test results (Figure I). 109 
 110 
Temocillin enrichment culture  111 
Due to an OXA-48 outbreak in a surgical ward (June 2016 – current), direct culture was compared to 112 
temocillin enrichment culture. Enrichment culture was specifically designed to recover OXA-48-113 
producers, in addition to all other CPE. 114 
Rectal swabs (n = 95) were inoculated into 3 ml nutrient broth (Thermo ScientificTM OxoidTM) 115 
containing a temocillin (30µg) disc. After overnight incubation at 37°C turbid broths were sub-116 
cultured to mSuperCARBATM. Broths were set up in tandem with direct culture to assess the 117 
advantages of enrichment culture and compared using a paired t-test, with a p-value ≤0.05 118 
considered significant. Enterobacteriaceae were identified and underwent AST, as described above. 119 
 120 
CPE algorithm  121 
Identification of CPE was reported using an algorithm-based approach and the following interpretive 122 
rules: 1) Enterobacteriaceae resistant to meropenem and ertapenem, irrespective of other AST 123 
results, were reported as presumptive CPE; 2) Enterobacteriaceae resistant to temocillin and 124 
piperacillin-tazobactam, but susceptible to meropenem, were reported as presumptive OXA-48.  125 
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All presumptive CPE/OXA-48 isolates were referred for reference testing PCR. The recovery of CPE by 126 
direct plating and temocillin enrichment was compared using a two-tailed t-test, with a p-value 127 
≤0.05 considered significant. 128 
 129 
A second retrospective evaluation was performed for all suspected CPE, isolated between 130 
September 2016 and June 2017, from 215 CPE rectal swabs. 131 
At this stage, all swabs (n = 156/215) associated with the OXA-48 outbreak ward underwent 132 
temocillin enrichment culture, while swabs (n = 59/215) from all other wards underwent direct 133 
culture on mSuperCARBATM. All Enterobacteriaceae recovered were identified by MALDI-TOF and 134 
AST performed (Figure II). 135 
  136 
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Results  137 
Performance of faropenem (CAT-ID) in detecting CPE  138 
Retrospective evaluation of faropenem disc testing of 25 CPE rectal screens and 482 diagnostic 139 
isolates identified 63/507 (12.4%) faropenem resistant Enterobacteriaceae as presumptive CPE. 140 
However, the reference laboratory PCR identified carbapenemases in only 14/63 (22%) of these – 3 141 
with NDM and 11 with OXA-48-like carbapenemases(Figure I). A further 16/444 ‘CPE negative’ 142 
isolates sent for reference PCR, due to resistance to ≥1 of temocillin, piperacillin-tazobactam, 143 
ertapenem and meropenem, revealed that 10/16 (62 %) produced an OXA-48-like carbapenemase. 144 
Together these results suggest a true-positive rate of 58%, a false-positive rate of 77% and an 145 
approximate false-negative rate of 2% for faropenem disc testing  for he detection of CPE.  146 
 147 
As faropenem susceptibility was deemed a poor predictor of carbapenemase production, AST results 148 
were reviewed to identify possible indicator antibiotics (Table I). All three NDM isolates were 149 
resistant to meropenem, ertapenem and piperacillin-tazobactam and 2/3 were temocillin-resistant. 150 
All twenty-one OXA-48 producers were temocillin-resistant and 20/21 (95%) were also resistant to 151 
piperacillin-tazobactam. Only 2/21 (10%) OXA-48 producers were meropenem-resistant and only 152 
11/21 (52%) were ertapenem-resistant. These findings informed a resistance algorithm with two 153 
phenotypic groups for isolates recovered on mSuperCARBATM. Group 1: isolates with resistance to 154 
meropenem and ertapenem were reported as presumptive CPE; group 2: isolates with resistance to 155 
temocillin and piperacillin-tazobactam were reported as presumptive OXA-48 producers.  156 
Using this algorithm 23/24 (96%) CPE recovered on selective media would have been correctly 157 
identified with only 1/24 (4%) falsely identified as negative. 158 
 159 
Temocillin enrichment culture  160 
During the investigation of the CPE outbreak, enrichment with temocillin increased the number of 161 
CPE recovered from 3% (3/95) to 12% (11/95), all of which were subsequently shown to produce 162 
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OXA-48 by reference PCR. As the increase in recovery was found to be significant (P = 0.03), 163 
temocillin enrichment was added to our optimised CPE screening protocol, along with the existing 164 
antibiotic resistance-based algorithm. 165 
 166 
After the combination of temocillin enrichment and AST algorithm was introduced into the CPE 167 
screening protocol, a further  evaluation was performed to determine the performance of the new 168 
method (Figure II). Presumptive CPE were then identified in 94% (203/215) of CPE rectal screens, of 169 
which 185/203 were confirmed by reference PCR (18 NDM and 167 OXA-48). Together these results 170 
demonstrated a true positive rate of 91% and a false-positive rate of 8% for the new protocol. 171 
Statistical analysis revealed that temocillin enrichment significantly increased the recovery of all CPE 172 
compared to direct culture (P = 0.01). Antibiotic resistances are detailed in table I. 173 




Discussion  176 
In our experience, accurate detection of OXA-48, the predominant carbapenemase in our institution, 177 
has been a significant problem. The initial approach combining selective chromogenic media 178 
(mSuperCARBATM) with faropenem resistance (CAT-ID discs) appeared sub-optimal. Despite reports 179 
of faropenem performing well, we found it to be a poor predictor of OXA-48 producers (58% true-180 
positives).8, 11 Similarly Koroska et al (2017) demonstrated a sensitivity of only 57.1% when using 181 
CAT-ID to explicitly identify OXA-48.6 In addition, our OXA-48 producers were typically meropenem 182 
and ertapenem susceptible (table I) in contrast to  previous studies with only carbapenem-resistant 183 
isolates, demonstrating that resistance to faropenem alone may miss many OXA-48 producers.8, 11  184 
 185 
Furthermore, AST results between March and August 2016 revealed that meropenem and 186 
ertapenem resistance (10% and 52%, respectively) were also unreliable indicators of OXA-48 187 
production, in contrast to temocillin resistance (100%). Therefore, faropenem resistance was 188 
replaced with interpretive reading of the antibiogram to ensure optimal recovery of all OXA-48 189 
producers.  190 
 191 
CPE enrichment using ertapenem or imipenem is well documented, but temocillin enrichment to 192 
improve recovery of OXA-48 producers is not.5, 9, 10, 12 We found temocillin enrichment significantly 193 
increased the recovery of OXA-48 CPE, both during the validation period and once it was introduced 194 
into our CPE screening protocol (Figure II). Four temocillin-susceptible NDM-producing isolates, 195 
recovered from diagnostic samples, may have been missed using the enrichment protocol alone, but 196 
were recovered by direct culture. This demonstrates the importance of a multi-faceted approach to 197 
CPE screening (temocillin enrichment for OXA-48 producers and direct culture for all other CPE), 198 
which allows all possible susceptibility profiles. By introducing temocillin enrichment and 199 
interpretive reading of AST results, we reduced the rate of isolates falsely reported as CPE from 77% 200 
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(faropenem method) to 8% demonstrating that a one-fits-all approach is unrealistic for precise CPE 201 
detection. Accurate reporting of CPE is important in prioritising limited infection control resources, 202 
but comes with a compromise, as temocillin enrichment adds 24 hours to the laboratory processing 203 
times and increases costs. 204 
 205 
Other studies have proposed diagnostic algorithms for CPE screening; employing faropenem and 206 
temocillin susceptibility to differentiate non-CPE, CPE and OXA-48 producers.6, 11 While they show 207 
that a combination of methods increases the sensitivity of CPE detection, there are also 208 
disadvantages. One relied on reduced carbapenem susceptibility to trigger a confirmatory CPE test 209 
(CAT-ID), which isunlikely to be practical if the majority of OXA-48 producers are carbapenem 210 
susceptible.11 Another study detected OXA-48 using a lateral flow device (LFD) to compensate for 211 
the poor performance of faropenem.6 While simple and rapid, LFD devices capable of detecting 212 
carbapenemases also increase CPE screening costs and may limit widespread use in high-throughput 213 
diagnostic laboratories.    214 
 215 
We have developed a robust and affordable protocol for identifying CPE from rectal swabs, which 216 
has the flexibility of identifying carbapenemases in isolates with variable susceptibility to β-lactams, 217 
including OXA-48. The inclusion of a temocillin enrichment step combined with an algorithm-based 218 
interpretation of AST results enabled detection of all CPE from rectal screens with a high degree of 219 
accuracy. The algorithm enabled us to harmonise differing methodologies used in carbapenem 220 
susceptibility testing and CPE screening into a single protocol able to inform both treatment and 221 
infection prevention and control strategies.  222 
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